Cochlear’s newer implant models and big spending on cloud systems and research could keep profits under pressure even as demand for hearing implants stays steady. See why strong growth in emerging markets and new ways to reach older adults may not translate into faster earnings any time soon.Read more
Cochlear bets that an aging world and better awareness of hearing loss will bring more people into treatment, while new “smart” implant technology helps it stand out. But tougher pricing, slower demand in some regions, and rising costs could make that growth bumpier than many expect.Read more
Catalysts About Cochlear Cochlear develops and manufactures implantable hearing solutions for people with severe to profound hearing loss. What are the underlying business or industry changes driving this perspective?Read more
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The company was founded in 1981 and is headquartered in Sydney, Australia.
